# Concurrent Bupropion / Varenicline for Smoking Cessation

> **NCT01303861** · PHASE3 · COMPLETED · sponsor: **Duke University** · enrollment: 702 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Bupropion
- **DRUG:** Nicotine patches
- **DRUG:** Nicotine Inhaler

## Key facts

- **NCT ID:** NCT01303861
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-03
- **Final completion:** 2013-07
- **Target enrollment:** 702 (ACTUAL)
- **Last updated:** 2014-08-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01303861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01303861, "Concurrent Bupropion / Varenicline for Smoking Cessation". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT01303861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*